Medikamente Zielsicher – Eine Elektrisch Gesteuerte Freisetzung
Vienna researchers developed a new way to control medicine release using electricity and click chemistry. This could make treatments more effective and reduce side effects.
#PrecisionMedicine, #DrugDelivery, #TUViennna, #MedicalResearch, #ClickChemistry
https://newsletter.tf/vienna-scientists-control-medicine-release-electricity/
This new technology allows doctors to control exactly when and where medicine is released, unlike older methods that sent medicine all over the body.
#PrecisionMedicine, #DrugDelivery, #TUViennna, #MedicalResearch, #ClickChemistry
https://newsletter.tf/vienna-scientists-control-medicine-release-electricity/
Iconovo and Lonza Enter LOI for Strategic Partnership
Iconovo and Lonza have signed a Letter of Intent to establish a long-term collaboration focused on inhalable biologics. This agreement aims to secure their respective positions in the biological medicines sector. Jan Vertommen, VP at Lonza, confirmed the company's interest in inhalable therapies and the intent to expand cooperation with Iconovo.
Nhà khoa học trẻ TP.HCM phát triển vật liệu nano dẫn truyền thuốc trúng đích, hứa hẹn mở ra hướng mới trong điều trị ung thư. #nanotechnology #cancerresearch #TPHCM #khoahọc #y học #đột phá
#materials #science #research #oncology #innovation #Vietnam #HCMC #nanomaterials #drugdelivery #targetedtherapy
Microneedles that could revolutionize cancer immunotherapy.
Made from natural polysaccharides, the new microneedles not only deliver drugs but also activate the immune system, paving the way for more effective and less invasive anticancer therapies.
Read more: https://omniletters.com/microneedles-that-could-revolutionize-cancer-immunotherapy/
#CancerImmunotherapy #Microneedles #Immunotherapy #CancerResearch #Oncology #DrugDelivery #TransdermalDelivery #Biomaterials #Polysaccharides #Nanomedicine #science #cancer
MIT just took a swing at one of the most annoying parts of modern medicine: hours‑long IV antibody infusions.
Their team figured out how to pack antibodies into tiny solid particles—about 100 microns wide—that stay suspended in liquid at ~360 mg/mL. That’s concentrated enough to deliver a full dose in about 2 mL, i.e., a normal subcutaneous injection, not a 100 mL drip.
https://mit-ki.org/4aHnV27
#Biotech #Oncology #DrugDelivery #MIT
MIT engineers discovered a way to make solid particles of highly concentrated antibodies, suspended in a solution. The advance represents a major step toward re-formulating antibodies so that they can be injected using a standard syringe.
🧬 Can molecular simulations transform the future of long-acting diabetes treatments?
🔗 In silico investigations of albumin-GLP-1 receptor agonist complexes for diabetes drug delivery applications. Computational and Structural Biotechnology Journal, DOI: https://doi.org/10.1016/j.csbj.2025.11.007
📚 CSBJ: https://www.csbj.org/
#MolecularDynamics #DiabetesResearch #Biotherapeutics #GLP1 #Albumin #DrugDelivery #Biomaterials #ComputationalBiology #ProteinEngineering
NewsletterTF
Biostock
Industry Examiner
VTC News Bot
Omni Letters
Sinclair Ta
Newsramp
CSBJ
Markus Witzler